Principles and therapeutics of cancer

被引：0
|
作者：
Lee, Yoontae [1 ]
机构：
[1] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea
来源：
MOLECULES AND CELLS | 2025年 / 48卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
HETEROGENEITY; HALLMARKS;
D O I：
10.1016/j.mocell.2025.100201
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Advances in Cancer Therapeutics
    Dang, Shweta
    Baboota, Sanjula
    Ali, Javed
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (45) : 4513 - 4514
  • [32] Individualised cancer therapeutics: dream or reality? Therapeutics construction
    Shen, YQ
    Senzer, N
    Nemunaitis, J
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1427 - 1441
  • [33] Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees
    Hughes, Dyfrig
    Reynolds, D. John M.
    CLINICAL MEDICINE, 2009, 9 (05) : 490 - 492
  • [34] CMET AS A TARGET FOR CANCER THERAPEUTICS
    LoRusso, P. Mucci
    ANNALS OF ONCOLOGY, 2008, 19 : 35 - 35
  • [35] Double Knockout in Cancer Therapeutics
    不详
    CELL, 2009, 139 (05) : 835 - 837
  • [36] Combinational therapeutics to combat cancer
    Al Otaibi, Ahmed
    Sherwani, Subuhi
    Alshammari, Eida Mohammed
    Al-Zahrani, Salma Ahmed
    Khan, Wahid Ali
    Alsukaibi, Abdulmohsen Khalaf Dhahi
    Dwivedi, Sourabh
    Khan, Shahper Nazeer
    Khan, Mohd Wajid Ali
    BIOINFORMATION, 2020, 17 (07) : 673 - 679
  • [37] CANCER THERAPEUTICS: SMART AND SMARTER
    Gilchrest, B. A.
    Eller, M. S.
    DRUGS OF THE FUTURE, 2009, 34 (03) : 205 - 216
  • [38] PNAs as novel cancer therapeutics
    Luca Mologni
    Carlo Gambacorti-Passerini
    Letters in Peptide Science, 2003, 10 : 297 - 308
  • [39] STING Agonists as Cancer Therapeutics
    Amouzegar, Afsaneh
    Chelvanambi, Manoj
    Filderman, Jessica N.
    Storkus, Walter J.
    Luke, Jason J.
    CANCERS, 2021, 13 (11)
  • [40] Minimizing Risk of Cancer Therapeutics
    Clark, Megan
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2018, 29 (04) : 701 - 719
12345